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Summary
 
Background
 
Ghrelin, a peptide hormone that plays a role in the
regulation of appetite and body adiposity, may also play a role in
bone metabolism.
 
Objectives
 
We used the opposite-sex twin model to study associ-
ations of plasma ghrelin levels with measures of bone mass and body
composition, and determine how such associations were influenced
by gender and age.
 
Patients and measurements
 
We measured total plasma ghrelin
by radioimmunoassay (RIA) and bone mass/body composition
parameters by dual energy X-ray absorptiometry in 79 pairs of oppo-
site sex twins (
 
n
 
 
 
=
 
 158 subjects). To examine the effect of age, the
study population was divided by median age into two groups: under
51·2 years (38 pairs) and over 51·2 years (41 pairs).
 
Results
 
Women had higher plasma ghrelin levels than men
(median 1063 
 
vs.
 
 869 ng/l, 
 
P
 
 < 0·01). Age was a significant predictor
of plasma ghrelin levels after adjustment for gender, fat mass and
body size. In the older age group, plasma ghrelin levels were inversely
associated with fat mass measures in men and women, but there were
gender differences in the nature of these associations. In women,
plasma ghrelin correlated inversely with body mass index (BMI,
 
r
 
 
 
=
 
 
 
−
 
0·32), total fat mass (
 
r
 
 
 
=
 
 
 
−
 
0·30) and fat mass/lean mass ratio
(
 
r
 
 
 
=
 
 
 
−
 
0·42), whereas in men associations with abdominal fat mass
(
 
r
 
 
 
=
 
 
 
−
 
0·31) and fat distribution index (
 
r
 
 
 
=
 
 
 
−
 
0·33) were observed.
Plasma ghrelin was associated with alcohol consumption in
older men and women. In the obese subgroup (BMI > 30) no sig-
nificant gender differences in plasma ghrelin were found. Plasma
ghrelin levels were not significantly associated with bone mineral
density (BMD) generally, except for hip BMD in younger women
(
 
r
 
 
 
=
 
 
 
−
 
0·39).
 
Conclusion 
 
Plasma ghrelin levels are associated with age, gender,
alcohol intake and fat mass measures but only weakly to bone mass
measures.
(Received ?????? 2006; returned for revision ?????? 2006; finally revised 
 
?????? 2006; accepted ?????? 2006)
 
Introduction
 
Ghrelin is a recently described peptide hormone that is secreted by
endocrine cells in the gastrointestinal tract.
 
1
 
 It has been shown that
ghrelin stimulates appetite, promotes adipogenesis, decreases energy
metabolism, and stimulates cortisol release,
 
1–7
 
 all of which poten-
tially affect bone metabolism indirectly. In humans, plasma ghrelin
levels increase during fasting and decrease following feeding.
 
8
 
 The
ghrelin receptor, known as the growth hormone secretagogue recep-
tor (GHS-R), is found in many organs, including the stomach, heart,
lung, pancreas, intestine, kidney, testes and ovary, as well as in the
hypothalamus and in adipose tissues.
 
1–3,7,9–12
 
 The wide distribution
of this receptor indicates that ghrelin, which is produced in and
secreted mainly from the stomach, may have a variety of regulatory
functions both in the brain and peripheral tissues.
 
13
 
 A recent 
 
in vitro
 
study of Maccarinelli 
 
et al.
 
 demonstrated an increase in osteoblast
proliferation after ghrelin administration.
 
14
 
 Moreover, a study of
Fukushima 
 
et al.
 
 has reported that ghrelin directly promotes bone
formation and increases BMD in rats.
 
12
 
 The reports on relationship
between plasma ghrelin levels and bone in humans are contradictory.
While Misra 
 
et al.
 
 reported that ghrelin was an independent predictor
of bone density at the lumbar spine and the hip in healthy adoles-
cents girls,
 
15
 
 the studies of Weiss 
 
et al.
 
 in the large cohort of men and
postmenopausal women of Rancho Bernardo, ??, USA and Oh 
 
et al.
 
in middle-aged Korean men found no association between serum
ghrelin levels and BMD.
 
16,17
 
 Numerous studies reported that plasma
ghrelin levels are associated with body composition measures such
as BMI and body fat mass.
 
18–23
 
 These findings, together with the
evidence that growth hormone (GH) is well known to promote bone
formation,
 
24–26
 
 raise the possibility that ghrelin may play a role in
bone metabolism.
There have been only a few studies that reported gender differ-
ences in plasma ghrelin levels and the findings of these studies have
been contradictory. Thus some authors did not find any sex differ-
ences in plasma ghrelin levels,
 
17,20,22,23,27,28
 
 whereas others reported
higher basal plasma ghrelin levels in females.
 
19,21,29,30
 
 The effect of
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age on plasma ghrelin levels also remains uncertain.
 
19,22,28
 
 In the
present study, we examined the associations of plasma ghrelin levels
with measures of bone, body composition and lifestyle factors and
whether any such associations were influenced by gender or age.
 
Materials and methods
 
Subjects
 
Study subjects were healthy adult (over 18 years old) opposite-sex
twin pair volunteers recruited as part of the Northern Sydney Twin
Study at the Department of Rheumatology of the Royal North Shore
Hospital, Australia. Subjects taking medications that could poten-
tially affect results were not excluded, but such medications were
recorded (see 
 
Results
 
 section). The hospital’s Human Research Ethics
Committee approved the study. Some of these data have been
reported elsewhere.
 
31,32
 
 After providing written informed consent,
each twin was interviewed separately in accordance with a standard
questionnaire to collect demographic, lifestyle and medical history data.
 
Body composition and bone mineral density 
measurements
 
Baseline characteristics included age, height (m), weight (kg), BMI
(weight/height
 
2
 
), and menopausal status for women. Lifestyle char-
acteristics included smoking, alcohol intake and physical activity.
Smoking was recorded as 0 – never smoked, 1 – current smoker
and 2 – previous smoker. Alcohol consumption was categorized as
1 – never, social occasions only, 2 – up to 14 drinks per week and 3
– more than 14 drinks per week.
 
33
 
 Physical activity was recorded as
the sum of work, home and leisure activities for the last 12 months,
graded from 1 – inactive to 4 – heavy).
Whole body, lumbar spine (L1–L4), hip and distal forearm were
scanned by fan-beam dual-energy X-ray absorptiometry (DEXA)
using a QDR 4500 W (Hologic, Waltham, MA. USA). Bone mineral
density (BMD) of the lumbar spine (LSBMD), total hip (HIPBMD)
and forearm (FORBMD) were obtained from DEXA scans using
standard protocols as previously described.
 
31,32
 
Total body BMD (TOT BMD), total fat mass (TOT FM), trunk
fat mass (TRUNK FM), total lean mass (TOT LM) were obtained
directly from whole body DEXA body composition analysis. The
abdominal fat (ABD FM) region was defined by cursor manipulation
extending between the top of the second and the bottom of the
fourth lumbar vertebrae and laterally to the inner aspects of the rib
cage.
 
34
 
 All scans were analysed by one operator. The intraobserver
variation of ABD FM was assessed by the calculating intraclass
correlation coefficient (ICC) and the coefficient of variation (CV) of
30 repeat scans. The ICC 
 
=
 
 0·998 (
 
P <
 
 0·001) and CV 
 
=
 
 1·5%. Leg fat
mass (LEG FM) was calculated as the sum of both leg’s fat mass. Body
fat distribution was assessed by trunk/leg fat mass ratio (TR FM/LEG
FM).
 
35
 
 Total fat mass to total lean mass ratio (TOT FM/TOT LM)
was also calculated from the DEXA scan.
Total plasma ghrelin levels were measured by radioimmunoassay
(RIA) using a double antibody/PEG technique (Linco Research Inc,
St Charles, MO, USA). This assay has a sensitivity of 93 ng/l with an
intra-assay precision of 10%. Samples were run in duplicates.
 
Statistical analysis
 
Mean values for the measured variables were compared between the
male and female co-twins, using paired 
 
t
 
-tests. The Mann–Whitney
test was run to compare non-normally distributed data of plasma
ghrelin levels. Uni- and multivariate regression analyses were
performed to evaluate the strength of relationship between plasma
ghrelin levels and body composition or bone mineral variables.
Generalized estimating equation (GEE) models were used to take into
account similarities between twin family members, when all study
subjects were pooled for the analyses. A 95% confidence interval was
used to describe the strength of association; 
 
P
 
 < 0·05 was considered
significant. The data set was evaluated for outliers, defined as those
lying outside 3 SD. All statistical analyses were performed using SPSS
for Windows 11·5 software (SPSS, Chicago, IL, USA).
 
Results
 
The characteristics of the 79 opposite-sex twin pairs are given in
Table 1. Their age ranged from 18 to 73 years. Among study subjects,
two men (1·3%) had diabetes mellitus, 13 (8·2%; 8 men, 5 women)
self-reported hypercholesterolaemia and were taking statins. No
patients were taking glitazones. Twenty-one participants were cur-
rent smokers (13·3%; 13 men, 8 women), 21 subjects (13·3%; 19
men, 2 women) were taking more than 14 units of alcohol per week.
Nineteen women were current and seven past HRT users. None of
the studied individuals were taking other medications affecting bone
metabolism. To examine the effect of age, twins were divided by
median into two age groups: under 51·2 years (38 pairs) and over
51·2 years (41 pairs). The median age cut point was used rather than
the menopause status of the female twin to simplify comparison
between genders, although the results were unchanged using the latter.
All females in the older age subgroup were postmenopausal.
In both age groups men were taller and heavier, had more lean
and abdominal fat mass but less total fat mass than women. The ratio
between trunk fat mass and leg fat mass was also higher in men of
any age indicating that in males, fat mass was mostly deposited in
the upper body.
Median plasma ghrelin levels were higher in women than in men
(1062·8 
 
vs.
 
 869·1 ng/l, 
 
P
 
 < 0·01). When compared within the age
subgroups, this difference was statistically significant in the younger
age group (1056·1 
 
vs.
 
 859·8 ng/l, 
 
P
 
 < 0·01). Comparison of plasma
ghrelin levels between genders of different age groups is presented
in Fig. 1.
To examine the association between plasma ghrelin levels and bone
density/body composition measures, nonparametric Spearman cor-
relations were performed. These correlations are presented in Table 2.
Plasma ghrelin levels did not show any significant correlation with
body composition measures in the younger age group in either gender.
Nor was it correlated with any of the lifestyle factors. In the older
age group, plasma ghrelin values were significantly correlated with
various fat mass measures in men and women. There were gender
differences in the nature of these associations. In women, plasma
ghrelin concentrations were inversely associated with total FM
(
 
r
 
 
 
=
 
 
 
–
 
0·299, 
 
P
 
 < 0·05) and FM/LM ratio (
 
r
 
 
 
=
 
 
 
–
 
0·419, 
 
P
 
 < 0·01),
whereas in men associations were seen with abdominal fat mass
2
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(
 
r
 
 
 
=
 
 
 
−
 
0·307, 
 
P
 
 < 0·05) and fat distribution TR FM/LEG FM ratio
(
 
r
 
 
 
=
 
 
 
−
 
0·334, 
 
P
 
 < 0·05). The correlation between abdominal fat mass
and ghrelin was weak and not statistically significant in women (
 
r
 
 
 
=
−
 
0·280, 
 
P
 
 > 0·05), while the correlation with fat distribution index
in women did not suggest any relationship (
 
r
 
 
 
=
 
 
 
−
 
0·081, 
 
P
 
 > 0·05). In
older women, plasma ghrelin levels were also associated with BMI
(
 
r
 
 
 
=
 
 
 
−
 
0·352, 
 
P
 
 < 0·05).
Alcohol intake was correlated with plasma ghrelin levels in older
men and women (
 
r
 
 
 
=
 
 0·490, 
 
P
 
 < 0·001 and 
 
r
 
 
 
=
 
 0·277, 
 
P
 
 < 0·05 for
men and women, respectively). Smoking was only associated with
ghrelin in older men (
 
r
 
 
 
=
 
 0·307, 
 
P
 
 < 0·05), while physical activity
showed significant correlations in older women (
 
r
 
 = 0·392, P < 0·05).
Plasma ghrelin levels were not associated with BMD in men of any
age. In women in the younger age group, plasma ghrelin levels showed
an inverse relationship with BMD, which was statistically significant
only for total hip (r = −0·390, P < 0·01) even after adjustment for fat
mass, body size and lifestyle factors (Table 3). In older women no
such relationships were also present.
The inverse association between plasma ghrelin levels and fat mass
measures lead us to investigate for differences in plasma ghrelin
between obese and normal subjects. We subdivided the dataset into
subgroups based on the World health Organization (WHO) obesity
classification.36 Thirty-five women (44·3%) and 24 men (30·4%) had
a normal BMI (18·51–24·99 kg/m2), 26 women (32·9%) and 38 men
(41·1%) were considered overweight (BMI: 25·00–29·99 kg m2), and
18 women (22·8%) and 17 men (21·5%) were obese (BMI ≥ 30 kg/m2).
Table 1. Characteristics of study subjects: comparison of gender and age subgroup
All Age under 51·2 (years) Age over 51·2(years)
Age subgroups
comparison 
(P-values) 
Men 
(n = 79)
Women 
(n = 79)
Men 
(n = 38)
Women 
(n = 38)
Men 
(n = 41)
Women 
(n = 41) Men Women
Age (years) 48·46 ± 13·24 37·48 ± 8·97 59·15 ± 5·85
Height (m) 1·76 ± 0·07 1·63 ± 0·07* 1·77 ± 0·07 1·64 ± 0·07* 1·76 ± 0·07 1·63 ± 0·06* 0·474 0·335
Weight (kg) 84·7 ± 14·2 70·6 ± 13·9* 85·1 ± 15·6 68·7 ± 15·1* 84·3 ± 13·1 72·34 ± 12·5* 0·819 0·249
BMI (kg/m2) 27·2 ± 3·8 26·5 ± 5·0 27·2 ± 4·3 25·6 ± 5·5 27·3 ± 3·2 27·3 ± 4·2 0·927 0·114
Total fat mass (kg) 19·1 ± 8·3 25·8 ± 10·5* 18·8 ± 9·6 22·8 ± 11·5 19·4 ± 6·8 28·8 ± 8·8* 0·749 0·012
Abdominal fat mass (kg) 2·1 ± 1·10 1·8 ± 1·0* 1·8 ± 1·1 1·4 ± 0·9* 2·4 ± 1·0 2·1 ± 0·9 0·020 0·000
Trunk fat / leg fat 2·1 ± 0·8 1·2 ± 0·5 1·6 ± 0·4 1·0 ± 0·3* 2·76 ± 0·8 1·4 ± 0·5* 0·000 0·000
Total lean mass (kg) 57·7 ± 7·1 38·8 ± 5·0* 58·4 ± 7·3 40·1 ± 5·3* 57·1 ± 7·0* 37·6 ± 4·4* 0·427 0·026
Fat mass/lean mass 0·33 ± 0·13 0·67 ± 0·24* 0·32 ± 0·15 0·57 ± 0·24* 0·3 ± 0·1 0·76 ± 0·2* 0·494 0·000
Ghrelin (ng/ l) 869·1 1062·8* 859·8 1056·1* 936·2 1115·9 0·094 0·665
(776–1275) (906–1374) (715–1159) (907–1356) (785–1385) (899–1405)
Categorical variables n (%)
Smoking
Never 39 (49·4%) 52 (65·8%) 23 (60·5%) 23 (60·5%) 16 (39%) 29 (70·7%)
Past 27 (34·2%) 19 (24·1%) 4 (10·5%) 11 (28·9%) 23 (56·1%) 8 (19·5%)
Current 13 (16·5%) 8 (10·1%) 11 (28·9%) 4 (10·5%) 2 (4·9%) 4 (9·8%)
Alcohol consumption
Never, rarely 20 (25·3%) 39 (49·4%) 9 (23·7%) 16 (42·1%) 11 (26·8%) 23 (56·1%)
Up to 14 units per week 40 (50·6%) 38 (48·1%) 23 (60·5%) 21 (55·3%) 17 (41·5%) 17 (41·5%)
More than 14 units per week 19 (24·1%) 2 (2·5%) 6 (15·8%) 1 (2·6%) 13 (31·7%) 1 (2·4)
All data are presented as mean ± SD, except for ghrelin, where data shown as medians (25–75 percentile). P-values are age subgroups comparisons.
*Significantly different from men (P < 0·05).
For conversion of ghrelin from metric units to SI units: ng/l × 3·371 (pmol/l).
BMI, body mass index.
Fig. 1 Ghrelin levels comparison between genders of different age groups.
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The results are presented in Fig. 2. Obese women had lower geo-
metric mean plasma ghrelin levels compared to those in the overweight
or normal BMI range (973·9; 116·5 and 1219·2 ng/l, respectively).
The difference was statistically significant only between obese and
normal subgroups (P < 0·01). Geometric mean ghrelin levels were
also lower in obese men compared to overweight and normal, but
the difference was not statistically significant.
Women within the normal or overweight BMI range had signi-
ficantly higher plasma ghrelin levels to those in men of the same BMI
range (1219·2 vs. 1057·3 ng/l for normal and 1116·5 vs. 952·1 ng/l
for overweight women and men, respectively). There were no gender
differences in plasma ghrelin levels between the obese BMI sub-
groups though.
The results of multiple regression analyses with plasma ghrelin as
the dependent variable are presented in Table 4. In Model 1, gender,
age and BMI showed a statistically significant association with plasma
All (n = 79)
Age under 
51·2 (years)
(n = 38)
Age over 
51·2 (years)
(n = 41) 
Men Women Men Women Men Women
Age 0·129 0·068 0·190 0·250 −0·232 −0·063
Height (m) −0·053 0·002 −0·154 −0·168 0·043 0·155
Weight (kg) −0·147 −0·117 −0·158 −0·113 −0·130 −0·237
BMI (kg/m2) −0·168 −0·196 −0·063 −0·031 −0·270 −0·352*
Total fat mass (kg) −0·119 −0·163 −0·035 −0·018 −0·239 −0·299*
Abdominal fat mass (kg) –0·118 −0·137 −0·097 −0·023 −0·307* −0·280
Trunk fat/leg fat –0·099 −0·111 −0·277 −0·133 −0·334* −0·081
Total lean mass (kg) −0·085 −0·69 −0·191 −0·111 0·052 0·009
Fat mass/lean mass −0·099 −0·191 0·009 −0·045 −0·255 −0·419**
Categorical variables
Alcohol intake 0·207* 0·213* −0·190 0·163 0·490*** 0·277*
Smoking 0·235* −0·019 0·019 −0·023 0·307* −0·007
Physical activity 0·057 0·153 −0·087 −0·175 0·241 0·392*
Statins use 0·007 −0·098 −0·007 −0·157 −0·071 −0·097
HRT −0·024 0·064 −0·115
Bone mineral density (gms/cm2)
Whole body BMD 0·044 −0·061 −0·125 −0·205 0·183 0·054
Lumbar spine BMD 0·031 −0·118 −0·111 −0·197 0·149 −0·048
Total hip BMD 0·045 −0·164 −0·177 −0·390** 0·163 0·025
Total forearm BMD −0·014
−0·021 −0·215 −0·036 0·126 0·009
*P < 0·05; **P < 0·01; ***P < 0·001.
HRT, hormone replacement therapy; BMD, bone mineral density.
Table 2. Nonparametric correlations 
(Spearman) between ghrelin levels and body 
composition/bone mineral variables
Table 3. Multivariate regression analysis for hip bone mineral density (BMD) and ghrelin levels in women under 51·2 years of age
Unstandardized coefficients 
B Standard error
Standardized coefficients 
Beta P-value
(Constant) 1·569 0·484 0·003
Ghrelin log −0·091 0·041 −0·310 0·033
Abdominal fat mass 0·056 0·016 0·522 0·001
Height −0·015 0·204 −0·011 0·940
Smoking −0·023 0·016 −0·216 0·156
Fig. 2 Plasma ghrelin levels comparison between genders of different body 
mass index (BMI) groups.
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ghrelin levels. Of the different measures of fat mass, abdominal fat
mass showed the strongest association and hence was included in
Model 2. This model demonstrates that abdominal fat mass and
alcohol consumption were significant predictors of plasma ghrelin
levels independent of gender, age or body size (height). However, the
models explain only a small proportion of the variability in plasma
ghrelin concentrations (7–11%). Physical activity, smoking,
hormone replacement therapy or statins were not associated with
plasma ghrelin and did not change the results when included in the
regression models.
Comparison of plasma ghrelin levels of different categories of
alcohol intake is presented in Fig. 3. There were no significant
difference in plasma ghrelin levels between participants taking up to
14 units of alcohol per week (849·0 ng/l, n = 40 for men and
1141·0 ng/ l, n = 38 for women) and those who drink on social occa-
sions only or not at all (863·8 ng/ l, n = 20 and 1012·1 ng/l, n = 39
men and women, respectively), regardless of gender. Women and
men who had more than 14 drinks per week (1187·6 ng/l, n = 19 for
men and 2312·3 ng/ l, n = 2 for women) had significantly higher
plasma ghrelin levels.
The data was also analysed using a classic twin method approach
where intrapair differences were used as studied variables. Intra-pair
differences were obtained by subtracting the variable of the female
twin from the corresponding male twin. The results of multiple linear
regression analysis between intrapair gender differences in ghrelin
levels and differences in body composition measures are shown in
Table 5. The intrapair differences in ghrelin levels were associated
with those in abdominal fat mass and fat distribution, with the models
explaining 14% of the variance (P < 0·05), and total lean mass (15%,
P < 0·05), confirming the association between ghrelin and fat mass
measures showed by correlation and regression analysis.
Discussion
Since the discovery of ghrelin, relatively few studies have examined
its plasma levels in normal healthy populations and these have gen-
erally been in small samples.17,18,21–23,28 The study has confirmed that
there is a gender difference in plasma ghrelin levels. Plasma ghrelin
was affected by age and alcohol intake and inversely associated with
BMI and fat mass measures. The correlation between plasma ghrelin
levels and fat mass distribution index measured by DEXA in older
men is a novel finding, not previously reported. Bone density measures
were not related to ghrelin in general, except for a weak association
between hip BMD and plasma ghrelin levels in younger women.
Our observation that women had higher levels of plasma ghrelin
levels than men is in agreement with some previous reports19,21 but
contradict others where no gender differences were found.17,20,22,23,27,28
However, the majority of the previous studies had smaller numbers
of participants, and men and women were not matched for age.
In accordance with other studies, we observed that measures of
body composition, such as BMI or body fat mass, had inverse asso-
ciations with plasma ghrelin.18–22,37,38 In our study these associations
were significant only in the older age group. We also observed gender
differences in ghrelin/fat mass associations, which have not been
reported previously. In women plasma ghrelin levels had a stronger
relationship with BMI, total fat mass and fat mass/lean mass ratio
and in men with abdominal fat mass and fat distribution index. The
correlation between abdominal fat mass and ghrelin was weak and
not statistically significant in women, whereas the correlation with
fat distribution index in women did not suggest any relationship.
Associations with central obesity have been observed previously,
when measured as waist circumference and waist-hip-ratio.18,19
Table 4. Multiple regression analysis of covariates to plasma ghrelin 
concentration*
n = 158 B Standard error P-value
Model 1
Intercept 7·040 0·190 0·000
Gender 0·128 0·051 0·013
Age 0·004 0·002 0·050
BMI −0·017 0·006 0·004
Model 2
Intercept 7·162 0·020 0·000
Abdominal fat mass −0·068 0·020 0·001
Alcohol consumption 0·519 0·014 0·000
Gender 0·140 0·045 0·002
Age 0·005 0·002 0·036
Height** −0·377 0·334 0·260
Plasma concentrations of ghrelin (ng/l) have been log transformed for 
regression analyses. Log ghrelin is dependent variable.
*GEE-models were used for taking into account similarities between twin 
family members.
**Height was used instead of body mass index (BMI) as body size parameters 
to eliminate interaction between body weight and fat mass.
Fig. 3 Plasma ghrelin levels comparison between genders of different alcohol 
intake categories.
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It has been reported that plasma ghrelin levels are lower in obese
individuals than in normal controls,22,23 and decreased in morbidly
obese compared with nonmorbidly obese patients.27 Our study con-
firms some of these observations. Based on the BMI classification,36
obese subjects of either gender had lower plasma ghrelin levels com-
pared to those in overweight or normal BMI range. Women within
the normal or overweight BMI range had significantly higher plasma
ghrelin levels to those in men of the same BMI range. The difference
in plasma ghrelin levels between men and women in the obese BMI
subgroups, however, was not statistically significant, suggesting that
there is a stronger relationship with fat measures than with gender
in the obese population.
The effect of age on ghrelin levels also remains uncertain. In two
smaller studies, Shiiya et al.22 and Greenman et al.19 did not find
significant differences in plasma ghrelin concentrations by age or
gender in normal subjects. On the other hand Purnell et al.20 found
that plasma ghrelin levels were positively correlated with age in a
study of 60 subjects. We did not find statistically significant correlations
between ghrelin and age when twins were subdivided into gender
and age subgroups. When we pooled all the study subjects in the
multiple regression analysis (n = 158), age was a significant predictor
of plasma ghrelin levels after adjustment for gender, fat mass and
body size. However, age only accounted for 15–20% of the variance
in plasma ghrelin levels. Thus, statistical power might play a role in the
previous findings where study subject numbers were relatively small.
A study in rats by Fukushima et al. has reported that ghrelin
directly promotes bone formation and increases BMD in rats.12 In
the study by Ki Won Oh et al.,16 serum ghrelin levels were not cor-
related with BMD in middle-aged Korean men. In the recent study
of Weiss et al.17 the association between BMD measurement and
plasma ghrelin became nonsignificant after adjustment for BMI and
age. In our study, plasma ghrelin levels were not significantly asso-
ciated with bone mineral density (BMD) generally, except at one site
(i.e. total hip) in younger women. Previous studies have shown that
hip BMD has strong associations with body composition measures
and fat mass in particular.39–42 The weight-bearing nature of the hip
site might partly explain this relationship. Our previous study has
shown that the body composition/bone measure relationships were
stronger in younger women.42 The inverse relationship between
obesity and ghrelin reported earlier18–23 is confirmed by our results.
Thus the associations between plasma ghrelin levels and hip BMD
in younger women were consistent with the previous reports.
The results of our study confirm the inverse relationship between
obesity and ghrelin which has been reported earlier.18–23 We also
observed gender differences in ghrelin/fat mass associations, which
have not been reported previously. This study also suggests that in
the obese population the relationship between total plasma ghrelin
levels is stronger with fat measures than with gender. Our study also
showed that ghrelin levels were associated with alcohol intake. This
is in agreement with the findings of the Langenberg et al.43 and Kraus
et al.44 Kellokoski et al.45 have reported that oestrogen therapy
increases plasma ghrelin in postmenopausal women. Accordingly we
included hormone replacement therapy as a variable in the multiple
regression analysis. No effect was seen in our analysis, but only
19 women were currently taking hormone therapy.
This study has certain strengths and limitations. The main
strength of this study is that opposite-sex twins were used to make
gender comparisons of all the variables studied. Most previous stud-
ies have recruited men and women at best from the same population
and of a similar age distribution. The use of opposite-sex twin pairs
has the advantage of controlling for some of the important deter-
minants of bone mass and body size such as age, genetic influences
(half of the genetic make-up in opposite-sex twin is common to both
members of a twin pair) and some early childhood/adolescent influ-
ences on bone and body composition such as diet. The results of the
present study are based on a relatively large population of healthy
men and women. The wide range of age in our study population has
allowed us to observe age and gender differences in plasma ghrelin
levels and their relation to body composition and bone mineral
measures. Nevertheless more opposite-sex twins may have allowed
us to detect more subtle differences in the study variables. Although we
had greater power than many previous studies, we have also made
multiple comparisons. However, in general our comparisons
between groups were supported by the multiple regression analysis.
Table 5. Associations of intrapair differences ghrelin concentrations with intrapair differences in body composition
All Age under 51·2 (years) Age over (years) 51·2 
r β R2 r β R2 r β R2
Weight (kg) −0·06 −0·068 0·053 −0·299 −0·329 0·127 −0·06 −0·068 0·053
Total fat mass (kg) −0·185 −0·186 0·082 −0·221 −0·225 0·088 −0·185 −0·186 0·082
Abdominal fat mass (kg) −0·150 −0·170 0·071 −0·324* −0·324* 0·142 −0·150 −0·170 0·071
Trunk fat mass/leg fat mass −0·150 −0·170 0·071 −0·324* −0·324* 0·142 −0·150 −0·170 0·071
Total lean mass (kg) 0·17 0·204 0·077 −0·347* −0·439* 0·157 0·17 0·204 0·077
Total fat mass/total lean mass −0·203 −0·198 0·089 −0·155 −0·154 0·064 −0·203 −0·198 0·089
Plasma concentrations of ghrelin (ng/l) have been log transformed for analyses.
Intrapair differences were obtained by subtracting the measure of female from male member of pair.
All multivariable regression models were adjusted for intrapair differences in body size (height).
r represents partial correlation coefficient, β represents regression coefficients, R2 represents proportion of variation of differences in bone mineral density 
(BMD) explained by each model.
*P ≤ 0·05.
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Our study examined the hypothesis that ghrelin affects surrogate
measures of fracture risk such as bone density. Our study demon-
strated that in healthy subjects, plasma ghrelin levels were influenced
by age, gender and body composition measures such as fat mass.
However, we found no evidence that ghrelin plays a role in human
bone metabolism, as assessed by bone densitometry. This study suggests
that measurement of plasma ghrelin is unlikely to have clinical utility
in assessing bone health; however, further studies of the relationship
between ghrelin and other markers of bone metabolism, such as bio-
chemical markers of bone formation and resorption would be of
interest.
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